Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
9
×
life sciences
national blog main
national top stories
9
×
boston blog main
boston top stories
clinical trials
san francisco blog main
san francisco top stories
new york blog main
new york top stories
boston
deals
fda
investing
startups
biotech ipos
cancer
cancer drugs
third rock ventures
venture capital
alexion pharmaceuticals
biogen
blackstone group
cancer immunotherapy
david goldstein
depression
epilepsy
essential tremor
hepatitis b
ipo
kiran reddy
major depressive disorder
medicare
national
nonalcoholic steatohepatitis
perimenopausal depression
praxis precision medicines
revolution medicines
roche
What
research
9
×
medicines
biotech
drug
drugs
ipo
new
aims
cancer
companies
disease
ipos
praxis
precision
proteins
revolution
stop
way
week
alzheimer’s
annual
approach
arrival
assessed
attention
awards
backed
based
billions
bio
biotechs
called
cancer’s
caught
cause
causing
central
ceo
cities
cns
Language
unset
Current search:
biotech
×
" national top stories "
×
research
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Nominations Open for San Diego’s Inaugural Xconomy Awards
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More